Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
SYDNEY, April 10, 2025 /PRNewswire/ -- Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions, announced today that it has been named...
SINGAPORE, April 10, 2025 /PRNewswire/ -- Singapore business advisory firm VIVOS Pte. Ltd. is pleased to announce the successful completion of the sale and...